Clinical Trials
35 trialsEACH
University College, London
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma
St. Jude Children's Research Hospital
Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma
Massachusetts General Hospital
GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer
Genome & Company
AXAGIST
Maria Sklodowska-Curie National Research Institute of Oncology
SAMCO
Federation Francophone de Cancerologie Digestive
LATENT
AHS Cancer Control Alberta
FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC
Ludwig-Maximilians - University of Munich
AURA
Jules Bordet Institute
NPC - AXEL Study : Axitinib-Avelumab
Chinese University of Hong Kong
AVETRIC
Gruppo Oncologico del Nord-Ovest
Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma
Memorial Sloan Kettering Cancer Center
NET-002
Sunnybrook Health Sciences Centre
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
M.D. Anderson Cancer Center
Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)
SWOG Cancer Research Network
AVAIL-T
University of Birmingham
MERKLIN2
4SC AG
Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)
EMD Serono
ARIES
Consorzio Oncotech
Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
Hoosier Cancer Research Network
AVANA
Gruppo Oncologico del Nord-Ovest
INDUCOMAIN
Associació per a la Recerca Oncologica, Spain
Avelumab With Chemoradiation in Locally Advanced Rectal Cancer
Peter MacCallum Cancer Centre, Australia
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
Mayo Clinic
AVETUX
AIO-Studien-gGmbH
Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma
NYU Langone Health
Study of Avelumab and Cetuximab Plus Gemcitabine and Cisplatin in Participants With NSCLC
Merck KGaA, Darmstadt, Germany
Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer
University of Campania Luigi Vanvitelli
AveNEC
Johannes Gutenberg University Mainz
AvelumabHCC
Seoul National University Hospital
PICK-NEPC
Duke University
MS100070-0177
Samsung Medical Center
A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer
Effector Therapeutics
Avelumab in Refractory Testicular Germ Cell Cancer.
National Cancer Institute, Slovakia
GliAvAx
Universitair Ziekenhuis Brussel